Quantitative Phosphoproteomics Reveals Extensive Protein Phosphorylation Dysregulation in the Cerebral Cortex of Huntington’s Disease Mice Prior to Onset of Symptoms
Mees, Isaline, Tran, Harvey, Roberts, Anne, Lago, Larissa, Li, Shanshan, Roberts, Blaine R., Hannan, Anthony J., Renoir, Thibault
Published in Molecular neurobiology (01.04.2022)
Published in Molecular neurobiology (01.04.2022)
Get full text
Journal Article
Loss-of-function and gain-of-function studies refute the hypothesis that tau protein is causally involved in the pathogenesis of Huntington’s disease
Mees, Isaline, Li, Shanshan, Beauchamp, Leah C, Barnham, Kevin J, Dutschmann, Mathias, Hannan, Anthony J, Renoir, Thibault
Published in Human molecular genetics (22.06.2022)
Published in Human molecular genetics (22.06.2022)
Get full text
Journal Article
Phosphoproteomics implicates glutamatergic and dopaminergic signalling in the antidepressant-like properties of the iron chelator deferiprone
Uzungil, Volkan, Luza, Sandra, Opazo, Carlos M., Mees, Isaline, Li, Shanshan, Ang, Ching-Seng, Williamson, Nicholas A., Bush, Ashley I., Hannan, Anthony J., Renoir, Thibault
Published in Neuropharmacology (15.03.2024)
Published in Neuropharmacology (15.03.2024)
Get full text
Journal Article
Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
Mees, Isaline, Nisbet, Rebecca M., Hannan, Anthony J., Renoir, Thibault
Published in Journal of Huntington's Disease (01.01.2023)
Published in Journal of Huntington's Disease (01.01.2023)
Get full text
Book Review
Journal Article